Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Estrogen Replacement on Cardiometabolic Endpoints in Women With Primary Ovarian Insufficiency

NCT06866119 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT06866119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06866119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Estrogen Replacement on Cardiometabolic Endpoints in Women With Primary Ovarian Insufficiency
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Recruiting
Start date
June 22, 2026
Completion date
June 30, 2029
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endothelial function (fmd), estrogen replacement therapy, metabolic complications, premature menopause, primary ovarian insufficiency